Sort
39,280 grants matching “leukemia”
Role of C/EBPalpha in MDS and MDS Progression
$366,938Johns Hopkins University · R01 · FY2005 · HL
c-Abl and PKC-eta in Cell Development and Leukemia
$366,931Mark S. Schlissel · University Of California Berkeley · R01 · FY2006 · AI
Cellular and molecular basis of microRNA-29a Induced Acute Myeloid Leukemia
$366,860Christopher Y Park · Sloan-Kettering Inst Can Research · R01 · FY2013 · CA
Role of IDH Mutations in Acute Myeloid Malignancies
$366,860Craig B Thompson · Sloan-Kettering Inst Can Research · R01 · FY2015 · CA
Role of IDH Mutations in Acute Myeloid Malignancies
$366,860Craig B Thompson · Sloan-Kettering Inst Can Research · R01 · FY2013 · CA
Role of IDH Mutations in Acute Myeloid Malignancies
$366,860Craig B Thompson · Sloan-Kettering Inst Can Research · R01 · FY2017 · CA
Role of IDH Mutations in Acute Myeloid Malignancies
$366,860Craig B Thompson · Sloan-Kettering Inst Can Research · R01 · FY2016 · CA
Cellular and molecular basis of microRNA-29a Induced Acute Myeloid Leukemia
$366,860Christopher Y Park · Sloan-Kettering Inst Can Research · R01 · FY2015 · CA
Cellular and molecular basis of microRNA-29a Induced Acute Myeloid Leukemia
$366,860Christopher Y Park · Sloan-Kettering Inst Can Research · R01 · FY2016 · CA
Support for Infrastructure of Childhood Leukemia Environmental Research
$366,856Catherine Metayer · University Of California Berkeley · R24 · FY2021 · ES
Ah Receptor Dysregulation Alters Hematopoietic Stem Cells
$366,763Thomas A Gasiewicz · University Of Rochester · R01 · FY2014 · ES
Characterization of NUP205 as a haploinsufficient essential gene for the treatment of hematopoietic malignancies
$366,739Haijiao Zhang · Oregon Health & Science University · R37 · FY2025 · CA
CTCL immunobiology: lessons from alemtuzumab
$366,728Rachael Ann Clark · Brigham And Women'S Hospital · R01 · FY2015 · AR
Role of Bone Microenvironment in Tax Induced Malignancies
$366,723Katherine M Weilbaecher · Ohio State University · P01 · FY2010 · CA
A non-myeloablative conditioning regimen for hematopoietic stem cell transplantat
$366,718Hartmut Geiger · P2d, Inc. · R43 · FY2014 · HL
Identifying the pathways that drive progression of the MPNs to AML
$366,706John D Crispino · Northwestern University At Chicago · R01 · FY2019 · CA
Integrative predictive medicine to identify disease causes, develop cures, and optimize patient care
$366,688Cassie S Mitchell · Georgia Institute Of Technology · R35 · FY2025 · GM
Integrative predictive medicine to identify disease causes, develop cures, and optimize patient care
$366,688Cassie S Mitchell · Georgia Institute Of Technology · R35 · FY2024 · GM
Functional and Translational Epigenomics of Acute Lymphoblastic Leukemia
$366,681Michael L Cleary · Stanford University · R01 · FY2018 · CA
Massively Parallel Analysis of Integration in Therapeutic Gene Transfer
$366,650Frederic D Bushman · University Of Pennsylvania · R01 · FY2010 · AI
Roles of Mre11 in Lymphocyte Development and DNA Repair
$366,630David O Ferguson · University Of Michigan At Ann Arbor · R01 · FY2010 · HL
Doxorubicin cardiotoxicity and the protective effects of exercise
$366,619Ashley Smuder · University Of Florida · R01 · FY2019 · HL
Ancillary Studies in Clinical Trials - PRIMeR
$366,611Marcelo C. Pasquini · Medical College Of Wisconsin · R01 · FY2012 · HL
Role of Shp2 in FLT3-ITD induced leukemogenesis
$366,582Reuben Kapur · Indiana University Indianapolis · R01 · FY2023 · CA
Role of Shp2 in FLT3-ITD induced leukemogenesis
$366,582Reuben Kapur · Indiana University Indianapolis · R01 · FY2022 · CA